<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><?origin nihpa?><?iso-abbr Nature?><?submitter-system nihms?><?submitter-canonical-name Nature Publishing Group?><?submitter-canonical-id NATURE-STRUCTUR?><?submitter-userid 1045?><?submitter-authority publisher?><?submitter-login nature-structure?><?submitter-name Nature Publishing Group (obsolete)?><?domain nihpa?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">0410462</journal-id><journal-id journal-id-type="pubmed-jr-id">6011</journal-id><journal-id journal-id-type="nlm-ta">Nature</journal-id><journal-id journal-id-type="iso-abbrev">Nature</journal-id><journal-title-group><journal-title>Nature</journal-title></journal-title-group><issn pub-type="ppub">0028-0836</issn><issn pub-type="epub">1476-4687</issn></journal-meta><article-meta><article-id pub-id-type="pmcid">4231536</article-id><article-id pub-id-type="pmid">25391964</article-id><article-id pub-id-type="doi">10.1038/nature13973</article-id><article-id pub-id-type="manuscript">nihpa636238</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Radial glia require PDGFD/PDGFR&#x000df; signaling in human but not mouse neocortex</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lui</surname><given-names>Jan H.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref rid="FN3" ref-type="author-notes">4</xref></contrib><contrib contrib-type="author"><name><surname>Nowakowski</surname><given-names>Tomasz J.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref rid="FN3" ref-type="author-notes">4</xref></contrib><contrib contrib-type="author"><name><surname>Pollen</surname><given-names>Alex A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Javaherian</surname><given-names>Ashkan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref rid="FN2" ref-type="author-notes">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kriegstein</surname><given-names>Arnold R.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><email>kriegsteina@stemcell.ucsf.edu</email></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Oldham</surname><given-names>Michael C.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><email>oldhamm@stemcell.ucsf.edu</email></contrib></contrib-group><aff id="A1"><label>1</label>Department of Neurology</aff><aff id="A2"><label>2</label>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, 35 Medical Center Way, San Francisco, CA 94143</aff><author-notes><fn id="FN2" fn-type="present-address"><label>3</label><p>Present address: Gladstone Institute of Neurological Disease, 1650 Owens St, San Francisco, CA 94158</p></fn><fn id="FN3" fn-type="equal"><label>4</label><p>These authors contributed equally</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>20</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>13</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>13</day><month>5</month><year>2015</year></pub-date><volume>515</volume><issue>7526</issue><fpage>264</fpage><lpage>268</lpage><!--elocation-id from pubmed: 10.1038/nature13973--><permissions><license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms"><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p></license></permissions><abstract><p id="P1">Evolutionary expansion of the human neocortex underlies many of our unique mental abilities. This expansion has been attributed to the increased proliferative potential<sup><xref rid="R1" ref-type="bibr">1</xref></sup>, <sup><xref rid="R2" ref-type="bibr">2</xref></sup> of radial glia (RG; i.e. neural stem cells) and their subventricular dispersion from the periventricular niche<sup><xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R5" ref-type="bibr">5</xref></sup> during neocortical development. Such adaptations may have evolved through gene expression changes in RG. However, whether or how RG gene expression varies between humans and other species is unknown. Here we show that the transcriptional profiles of human and mouse neocortical RG are broadly conserved during neurogenesis, yet diverge for specific signaling pathways. By analyzing differential gene coexpression relationships between the species, we demonstrate that the growth factor <italic>PDGFD</italic> is specifically expressed by RG in human, but not mouse, corticogenesis. We further show that the expression domain of PDGFR&#x000df;, the cognate receptor<sup><xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref></sup> for PDGFD, is evolutionarily divergent, with high expression in the germinal region of dorsal human neocortex but not in the mouse. Pharmacological inhibition of PDGFD/PDGFR&#x000df; signaling in slice culture prevents normal cell cycle progression of neocortical RG in human, but not mouse. Conversely, injection of recombinant-PDGFD or ectopic expression of constitutively active PDGFR&#x000df; in developing mouse neocortex increases the proportion of RG and their subventricular dispersion. These findings highlight the requirement of PDGFD/PDGFR&#x000df; signaling for human neocortical development and suggest that local production of growth factors by RG supports the expanded germinal region and progenitor heterogeneity of species with large brains.</p></abstract></article-meta></front><body><p id="P2">RG are the physical substrate<sup><xref rid="R8" ref-type="bibr">8</xref></sup> and progenitor population that underlie production of most cells in human neocortex<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. We sought to determine a general transcriptional &#x0201c;signature&#x0201d; of human neocortical RG (hRG) as a starting point for identifying genes that may regulate uniquely human aspects of cortical development. We and others have previously shown that gene coexpression analysis of heterogeneous tissue samples can deconvolve transcriptional signatures of distinct cell types without cell isolation or purification<sup><xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref></sup>. Because prenatal samples of human neocortex are scarce, we developed a novel strategy called <bold>G</bold>ene <bold>C</bold>oexpression <bold>A</bold>nalysis of <bold>S</bold>erial <bold>S</bold>ections (<bold>GCASS</bold>) that exploits variation in cellular abundance across serial sections of a single tissue sample to reveal cell type-specific patterns of gene expression (<xref rid="F10" ref-type="fig">Fig. 1a-c</xref>; <xref rid="F1" ref-type="fig">Extended Data Fig. 1</xref>; see Supplementary Information for methods, rationale, and further discussion). We applied GCASS to 87 150&#x003bc;m sections of a single human cortical sample from gestational week 14.5 (GW14.5, corresponding to peak layer V neurogenesis<sup><xref rid="R11" ref-type="bibr">11</xref></sup>; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>) and identified 55 modules of coexpressed genes. Six modules overlapped significantly with a set of genes we determined were expressed significantly higher in FACS-sorted mouse RG (mRG) vs. intermediate progenitor cells (&#x0201c;FACS-mRG&#x0201d;: <xref rid="F1" ref-type="fig">Extended Data Fig. 1</xref>; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>), suggesting that they might represent transcriptional signatures of hRG (<xref rid="F10" ref-type="fig">Fig. 1d</xref>). Analysis of laser-microdissected samples from three independent transcriptomic datasets<sup><xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref></sup> confirmed that genes in these modules are most highly expressed in the ventricular zone (VZ) and subventricular zone (SVZ) of developing human neocortex, where both ventricular (vRG) and outer subventricular (oRG) subtypes of RG reside<sup><xref rid="R4" ref-type="bibr">4</xref></sup> (<xref rid="F2" ref-type="fig">Extended Data Fig. 2</xref>).</p><p id="P3">To produce a consensus transcriptional signature for GW14.5 hRG, we first summarized each of these six modules by its first principal component/module eigengene<sup><xref rid="R14" ref-type="bibr">14</xref>, <xref rid="R15" ref-type="bibr">15</xref></sup> (ME) and calculated the WGCNA<sup><xref rid="R16" ref-type="bibr">16</xref></sup> measure of intramodular gene connectivity, kME<sup><xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R14" ref-type="bibr">14</xref></sup> (concept: <xref rid="F10" ref-type="fig">Fig. 1c</xref>). kME quantifies the extent to which a gene conforms to the characteristic expression pattern of a module and can predict gene expression specificity for individual cell types<sup><xref rid="R10" ref-type="bibr">10</xref></sup>. kME values for the six modules were combined into a single measure (<italic>Z.hRG</italic>), with higher scores predicting greater expression specificity for hRG (<xref rid="F10" ref-type="fig">Fig. 1e</xref>). Genes with high <italic>Z.hRG</italic> included markers of neocortical RG such as <italic>SLC1A3</italic> (<italic>GLAST1</italic>), <italic>VIM</italic>, <italic>SOX2</italic>, <italic>NOTCH1</italic>, and <italic>PAX6</italic> (<xref rid="F10" ref-type="fig">Fig. 1e</xref>: blue lines). Genes with low <italic>Z.hRG</italic> included markers of committed neuronal lineages such as <italic>TBR1</italic>, <italic>FEZF2</italic>, <italic>RELN</italic>, and <italic>SATB2</italic> (<xref rid="F10" ref-type="fig">Fig. 1e</xref>: black lines). We performed <italic>in situ</italic> hybridization (ISH) and immunostaining on independent prenatal human neocortical samples for genes with high <italic>Z.hRG</italic> that have not, to the best of our knowledge, previously been implicated in RG biology (<xref rid="F10" ref-type="fig">Fig. 1e</xref>: red lines; <xref rid="F3" ref-type="fig">Extended Data Fig. 3</xref>). In all cases, expression of these genes was restricted to the VZ/SVZ (<xref rid="F10" ref-type="fig">Fig. 1f</xref>; <xref rid="F3" ref-type="fig">Extended Data Fig. 3</xref>). These results indicate that GCASS can discern a general transcriptional signature of hRG from a single, heterogeneous tissue sample without cell labeling, isolation, or purification. Moreover, because the sample derives from a single individual, this strategy implicitly controls for genotype and developmental stage and has broad implications for the molecular analysis of rare tissue samples.</p><p id="P4">To establish the robustness of the hRG transcriptional signature, we analyzed four additional prenatal human cortex gene expression datasets<sup><xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>, <xref rid="R17" ref-type="bibr">17</xref></sup> that were generated with diverse sampling strategies and technology platforms (<xref rid="T1" ref-type="table">Extended Data Table 1</xref>). In parallel, we also analyzed three embryonic mouse cortex gene expression datasets<sup><xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref></sup> (largely E14-14.5, corresponding to peak layer V neurogenesis<sup><xref rid="R11" ref-type="bibr">11</xref></sup>; <xref rid="T1" ref-type="table">Extended Data Table 1</xref>) to establish a robust mRG transcriptional signature. For each dataset, we constructed an unsupervised coexpression network, identified the module with the most significant overlap with the FACS-mRG gene set, and calculated kME values (RG.kME) for every gene with respect to this RG module (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>). To facilitate comparisons of RG transcriptional signatures, we mapped all probe sets/transcripts to a common identifier (HomoloGene ID) and converted RG.kME values for each dataset into percentile ranks (RG.PR; workflow schematic: <xref rid="F4" ref-type="fig">Extended Data Fig. 4</xref>). Genome-wide correlations of RG.PR among all datasets ranged from 0.36 &#x02013; 0.95 (human) and 0.47 &#x02013; 0.70 (mouse) (P &#x0003c; 2.2e-16; <xref rid="F5" ref-type="fig">Extended Data Fig. 5</xref>), demonstrating the robustness of RG transcriptional signatures in both species.</p><p id="P5">To explore the global extent of gene expression conservation between hRG and mRG, we calculated the mean RG specificity for each gene across the five human (<inline-formula><mml:math id="M1" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>hRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula>), three mouse (
<inline-formula><mml:math id="M2" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>mRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula>), and all eight (
<inline-formula><mml:math id="M3" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>RG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula>) datasets (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>). For genes present in at least one dataset in each species (n = 15,576), the correlation between 
<inline-formula><mml:math id="M4" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>hRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> and 
<inline-formula><mml:math id="M5" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>mRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> was 0.48 (P &#x0003c; 2.2e-16; <xref rid="F11" ref-type="fig">Fig. 2a</xref>), indicating broad conservation of transcriptional programs that are active during cortical development in humans and mice. Genes with 
<inline-formula><mml:math id="M6" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>hRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> and 
<inline-formula><mml:math id="M7" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>mRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> &#x0003e; 80 (<xref rid="F11" ref-type="fig">Fig. 2a</xref>, +RG box) or &#x0003c; 20 (<xref rid="F11" ref-type="fig">Fig. 2a</xref>, -RG box) were significantly enriched with sets of genes expressed by RG or neurons, respectively (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 4</xref>). Furthermore, the most conserved set of core RG genes (
<inline-formula><mml:math id="M8" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>hRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> and 
<inline-formula><mml:math id="M9" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>mRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> &#x0003e; 95: <xref rid="F11" ref-type="fig">Fig. 2a</xref>, green box) included the canonical RG markers <italic>VIM</italic> and <italic>PAX6</italic>, and <italic>SOX</italic> family members implicated in nervous system development such as <italic>Sox2</italic>, <italic>SOX3</italic>, <italic>SOX9</italic>, and <italic>SOX21</italic> (<xref rid="F11" ref-type="fig">Fig. 2b</xref>). Also present among this core set were elements of the Notch (<italic>NOTCH2</italic> and <italic>HES1</italic>) and Wnt-&#x003b2;catenin (<italic>SFRP1</italic>, <italic>FZD8</italic>, and <italic>LRP4</italic>) signaling pathways, which critically regulate neurogenesis<sup><xref rid="R2" ref-type="bibr">2</xref></sup>. In addition, we observed a cohesive subgroup of genes involved in cell cycle regulation, including <italic>CKS2</italic>, <italic>RACGAP1</italic>, <italic>MELK</italic>, <italic>CCNB1</italic>, <italic>CCNA2</italic>, <italic>ASPM</italic>, and <italic>MKI67</italic>. Finally, several genes in this group have not, to the best of our knowledge, previously been implicated in RG biology, including <italic>PSAT1</italic>, <italic>DDAH1</italic>, <italic>AIF1L</italic>, <italic>PSRC1</italic>, and <italic>ACSS1</italic>. Together, these results provide a framework for identifying conserved and distinct aspects of gene expression in hRG and mRG.</p><p id="P6">To identify evolutionary changes in RG gene expression that might underlie neurodevelopmental differences between human and mouse, we assessed homologous genes based on predicted differences in RG expression specificity between the species (differential RG specificity: 
<inline-formula><mml:math id="M10" overflow="scroll"><mml:mtext>DS</mml:mtext><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mrow><mml:mtext>hRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover><mml:mo>&#x02212;</mml:mo><mml:mover accent="true"><mml:mrow><mml:mtext>mRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula>). Because such differences could emerge from gene expression changes in RG or neighboring cell types (<xref rid="F11" ref-type="fig">Fig. 2c</xref>), we also compared the relative expression levels of homologous genes between the species (differential expression: 
<inline-formula><mml:math id="M11" overflow="scroll"><mml:mtext>DE</mml:mtext><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">h</mml:mi><mml:mo>.</mml:mo><mml:mtext>Expr</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover><mml:mo>&#x02212;</mml:mo><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mo>.</mml:mo><mml:mtext>Expr</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula>). Genome-wide analysis of DS/DE revealed four distinct quadrants of genes that differed substantially between human and mouse (<xref rid="F11" ref-type="fig">Fig. 2d</xref>). Consistent with the proposed model (<xref rid="F11" ref-type="fig">Fig. 2c</xref>), these quadrants were enriched with sets of genes expressed in distinct patterns in developing human and mouse cortex (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 4</xref>).</p><p id="P7">We reasoned that quadrant 1 might contain genes with &#x0201c;Boolean&#x0201d; expression differences (i.e. ON in hRG and OFF in mRG) required for human but not mouse neocortical development. We applied stringent criteria to identify and validate 18 candidate genes in this quadrant with strong and consistent evidence of expression in hRG and no evidence of expression in mRG: <italic>ABHD3</italic>, <italic>ASAP3</italic>, <italic>BMP7</italic>, <italic>C5</italic>, <italic>C8orf4</italic>, <italic>FAM107A</italic>, <italic>FOXN4</italic>, <italic>ITGA2</italic>, <italic>LRIG3</italic>, <italic>LRRC17</italic>, <italic>PAM</italic>, <italic>PDGFD</italic>, <italic>PDLIM3</italic>, <italic>RFTN2</italic>, <italic>SLC2A10</italic>, <italic>SP110</italic>, <italic>STOX1</italic>, and <italic>ZC3HAV1</italic> (<xref rid="F11" ref-type="fig">Fig. 2d</xref>, cyan circles; <xref rid="F6" ref-type="fig">Extended Data Fig. 6</xref>). Because secreted growth factors could alter the size of developing neocortex by influencing proliferation, we focused on <italic>PDGFD</italic> (<xref rid="F11" ref-type="fig">Fig. 2d</xref>', green square), which has not, to the best our knowledge, previously been implicated in cortical development of any species. Compared to genes with the highest 
<inline-formula><mml:math id="M12" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>RG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> (conserved in both species), <italic>PDGFD</italic> expression was highly correlated in human, but not mouse (<xref rid="F12" ref-type="fig">Fig. 3a-b</xref>). ISH confirmed that <italic>PDGFD</italic> was expressed by RG throughout the VZ of GW14.5 human neocortex (<xref rid="F12" ref-type="fig">Fig. 3c</xref>). In contrast, <italic>Pdgfd</italic> was not detected in RG (or any cell type) in E15.5 mouse neocortex (<xref rid="F12" ref-type="fig">Fig. 3d</xref>). These expression differences were consistent for multiple ages in human (GW14.5-GW18.2) and mouse (E14.5-E17.5) prenatal cortex (<xref rid="F7" ref-type="fig">Extended Data Fig. 7</xref>).</p><p id="P8">The effects of PDGFD are specifically mediated by the PDGFR&#x000df; receptor, which upon phosphorylation can trigger signaling pathways that promote cell proliferation<sup><xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R20" ref-type="bibr">20</xref></sup>. Although <italic>PDGFR&#x003b2;</italic> did not meet the same stringent criteria as <italic>PDGFD</italic>, its location on the DS/DE plot was proximal to <italic>PDGFD</italic> (<xref rid="F11" ref-type="fig">Fig. 2d</xref>', red square), also suggesting species differences in <italic>PDGFR&#x003b2;</italic> expression. Compared to genes with the highest 
<inline-formula><mml:math id="M13" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>RG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula>, <italic>PDGFR&#x003b2;</italic> expression was moderately correlated in human, but not mouse (<xref rid="F12" ref-type="fig">Fig. 3e-f</xref>). Immunostaining for PDGFR&#x000df; in GW14.5 human brain revealed strong expression throughout the telencephalic germinal zones (VZ/SVZ) and in vascular pericytes, with highest levels in dorsolateral cortical progenitors and the lateral ganglionic eminence (LGE) (<xref rid="F12" ref-type="fig">Fig. 3g</xref>). In contrast, immunostaining for PDGFR&#x000df; in E15.5 mouse brain revealed expression in LGE progenitors but no evidence of expression in cortical progenitors (<xref rid="F12" ref-type="fig">Fig. 3h</xref>). However, we did observe very low levels of <italic>Pdgfr&#x003b2;</italic> transcript in the VZ of lateral mouse cortex<sup><xref rid="R21" ref-type="bibr">21</xref></sup> (<xref rid="F8" ref-type="fig">Extended Data Fig. 8</xref>), leaving open the possibility of modest, region-specific function. Collectively, these results indicate that expression patterns of PDGFD and PDGFR&#x000df; in developing neocortex have diverged considerably during human and mouse evolution, despite retaining amino-acid sequences that are &#x0223c;85% identical between the species.</p><p id="P9">We tested the requirement of PDGFD/PDGFR&#x000df; signaling for hRG proliferation in GW17.5 human neocortical slice cultures, screening four chemical inhibitors of PDGFR&#x000df; signaling (Sutent, Tivozanib, Imatinib, and CP673451). Three out of four PDGFR&#x000df; inhibitors reduced the percentage of SOX2+ progenitors (RG) that incorporated BrdU over two days in slice culture (<xref rid="F9" ref-type="fig">Extended Data Fig. 9</xref>). For replication we focused on CP673451, which exhibits the greatest selectivity for PDGFR&#x003b2; over other receptors<sup><xref rid="R22" ref-type="bibr">22</xref></sup> and caused the greatest reduction in SOX2+BrdU+ cells among tested inhibitors (<xref rid="F9" ref-type="fig">Extended Data Fig. 9</xref>). PDGFR&#x000df; inhibition by CP673451 in GW17.5 human neocortical slice cultures reduced the number of RG and intermediate progenitors (IP) that incorporated BrdU by &#x0003e;50%, affecting progenitors in the VZ and SVZ (<xref rid="F13" ref-type="fig">Fig. 4a-b</xref>). The percentage of progenitor cells co-staining with cleaved caspase-3, an apoptosis marker, was slightly elevated by CP673451, but sufficiently low to attribute reduced BrdU incorporation to cell cycle dysregulation rather than cell death (<xref rid="F13" ref-type="fig">Fig. 4b</xref>). Furthermore, CP673451 treatment of E13.5 mouse cortical slice cultures did not decrease BrdU incorporation or the cycling proportion (Ki67+) of RG or IP populations over multiple time points (<xref rid="F13" ref-type="fig">Fig. 4b</xref>, <xref rid="F9" ref-type="fig">Extended Data Fig. 9</xref>). These results indicate that PDGFR&#x000df; signaling is required for hRG but not mRG to progress through the cell cycle and expand at a normal rate.</p><p id="P10">We next investigated whether introducing PDGFD into embryonic mouse cortex, where it is normally absent, could promote mRG proliferation. We injected recombinant-PDGF-DD protein into the lateral ventricles of E13.5 mouse embryos, bypassing the need for PDGFD to be generated and dimerized <italic>in vivo</italic>, and analyzed the number and spatial distribution of SOX2+ progenitors at E15.5 in lateral cortex. Relative to vehicle, PDGF-DD increased the proportion of RG (SOX2+/DAPI+) in lateral cortex by &#x0223c;10% (<xref rid="F13" ref-type="fig">Fig. 4c-d</xref>). Furthermore, PDGF-DD induced a modest subventricular shift in the distribution of mRG in the developing cortical wall (<xref rid="F13" ref-type="fig">Fig. 4d</xref>). These effects were not observed in dorsomedial cortex, where PDGFR&#x003b2; was not detected in RG (<xref rid="F13" ref-type="fig">Fig. 4c-d</xref>, <xref rid="F8" ref-type="fig">Extended Data Fig. 8</xref>).</p><p id="P11">To test if mRG can respond to PDGFR&#x003b2; activation, we ectopically expressed two forms of constitutively active PDGFR&#x003b2; (PDGFR&#x003b2;:D850V [homologous to human D849V<sup><xref rid="R23" ref-type="bibr">23</xref></sup>] or the TEL-PDGFR&#x003b2;<sup><xref rid="R24" ref-type="bibr">24</xref></sup> fusion protein) in mRG by <italic>in utero</italic> electroporation at E13.5. By E15.5, expression of PDGFR&#x003b2;:D850V approximately doubled the proportion of SOX2+ or Ki67+ progenitors among electroporated (GFP+) cells and dramatically dispersed SOX2+ progenitors in the basal direction (<xref rid="F13" ref-type="fig">Fig 4e-f</xref>; <xref rid="F9" ref-type="fig">Extended Data Fig. 9</xref>). Similar but less dramatic effects were observed following TEL-PDGFR&#x003b2; electroporation (<xref rid="F9" ref-type="fig">Extended Data Fig. 9</xref>). These results indicate that PDGFR&#x003b2; signaling in mRG functions analogously to its known role as an oncogenic pathway that promotes proliferation and epithelial-mesenchymal transition<sup><xref rid="R20" ref-type="bibr">20</xref></sup>. We therefore propose that physiological levels of PDGFD/PDGFR&#x003b2; signaling in hRG may contribute to the proliferation and subventricular dispersion of neural progenitors that characterizes OSVZ formation<sup><xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R5" ref-type="bibr">5</xref></sup>.</p><p id="P12">Mouse studies have demonstrated that the size and shape of cerebral cortex depend on precise regulation of molecular pathways controlling RG proliferation and differentiation<sup><xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref></sup>. While many of these pathways are likely to be conserved in humans, mouse studies alone cannot reveal uniquely human aspects of cortical development<sup><xref rid="R25" ref-type="bibr">25</xref>-<xref rid="R30" ref-type="bibr">30</xref></sup>. By analyzing human tissue as a starting point, we found that PDGFD/PDGFR&#x000df; signaling is required for normal RG proliferation in developing human but not mouse neocortex, and is sufficient to promote some &#x0201c;humanizing&#x0201d; characteristics in mouse. Our analysis has also identified other genes that likely contribute to differences between human and mouse cortical development. <italic>BMP7</italic>, another secreted growth factor, was predicted and validated to be expressed by hRG but not mRG (<xref rid="F11" ref-type="fig">Fig. 2d</xref>, <xref rid="F6" ref-type="fig">Extended Data Fig. 6</xref>), raising the intriguing possibility that local production of growth factors by hRG may be necessary to support the expanded germinal region and progenitor heterogeneity of developing human neocortex. We anticipate that the analytical and experimental strategies described here will help determine the extent to which these and other pathways are shared among primates or uniquely required for human cortical development.</p><sec sec-type="methods" id="S1"><title>Methods</title><p id="P13">Detailed descriptions of all experimental and bioinformatic procedures are provided in Supplementary Information.</p></sec><sec id="S2"><title>Extended Data</title><fig id="F1" orientation="portrait" position="anchor"><label>Extended Data Figure 1</label><caption><title>Human brain dissection for GCASS and schematic for generation of FACS-mRG dataset</title><p id="P14"><bold>a,</bold> Top: To generate the GCASS dataset, an almost-intact prenatal human telencephalic hemisphere (GW14.5) was microdissected to separate the dorsal telencephalon from the ventral telencephalon (including medial and lateral ganglionic eminences). Bottom: The dorsal fragment was flash-frozen and serially sectioned (150 &#x003bc;m) for transcriptional profiling with Illumina HT-12 v4 Beadchip microarrays (scale bars 2.5 mm). <bold>b,</bold> To generate the FACS-mRG dataset, dorsal neocortices of Eomes:GFP mouse embryos were microdissected, pooled (n = 3 litters, 5-8 pooled embryos per litter), dissociated, and FACS-sorted according to the gating scheme depicted to isolate RG and IP cells. Transcriptional profiling of the resultant populations was performed using Illumina mouseRef-8 v1.0 Beadchip microarrays.</p></caption><graphic xlink:href="nihms636238f1"/></fig><fig id="F2" orientation="portrait" position="anchor"><label>Extended Data Figure 2</label><caption><title>Genes comprising the six RG coexpression modules identified by GCASS are expressed in a manner consistent with the known distribution of RG in developing human neocortex</title><p id="P15">Six candidate hRG gene coexpression modules (<xref rid="F10" ref-type="fig">Fig. 1d</xref>) were superimposed on three independent gene expression datasets generated from laser-microdissected samples from prenatal human cortex: ABI.1<sup><xref rid="R13" ref-type="bibr">13</xref></sup> (GW17), ABI.2<sup><xref rid="R13" ref-type="bibr">13</xref></sup> (GW18), and Fietz et al.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> (GW15-18) (as listed in <xref rid="T1" ref-type="table">Extended Data Table 1</xref>). The characteristic expression patterns of the superimposed modules were summarized by singular value decomposition; the first principal component (PC1) for each module in each dataset is shown. In all cases, PC1 revealed substantially higher expression levels for these genes in germinal zones (VZ, ISVZ, and OSVZ, highlighted in red) vs. non-germinal zones (IZ, SP, ICP, OCP, CP, MZ, SG). Permutation analysis indicated that the percent variance explained (VE) by PC1 of each superimposed module was significantly greater than expected by chance (n = 10,000 permutations). VZ: ventricular zone, ISVZ: inner subventricular zone, OSVZ: outer subventricular zone, IZ: intermediate zone, SP: subplate, ICP: inner cortical plate, OCP: outer cortical plate, CP: cortical plate, MZ: marginal zone, SG: subpial granular layer, GW: gestational week, CTX: cortex.</p></caption><graphic xlink:href="nihms636238f2"/></fig><fig id="F3" orientation="portrait" position="anchor"><label>Extended Data Figure 3</label><caption><title>GCASS successfully predicts novel markers of neocortical hRG</title><p id="P16"><bold>a,</bold> Genome-wide distribution of predicted GW14.5 neocortical hRG expression specificity (<italic>Z.hRG</italic>). Red lines: predicted RG genes (validated in <bold>b-c</bold>). <bold>b-c,</bold> Immunostaining and <italic>in situ</italic> hybridization in GW14.5 human neocortex confirms RG expression specificity for novel candidate markers predicted in (<bold>a</bold>) (<bold>b,</bold> scale bar 50 &#x003bc;m; <bold>c,</bold> scale bar 100 &#x003bc;m). Analyzed tissue sections were independent from the sample used for microarray analysis (<xref rid="F10" ref-type="fig">Fig. 1a</xref>). VZ: ventricular zone, (I/O)SVZ: (inner/outer) subventricular zone.</p></caption><graphic xlink:href="nihms636238f3"/></fig><fig id="F4" orientation="portrait" position="anchor"><label>Extended Data Figure 4</label><caption><title>Workflow of bioinformatic procedures and experimental rationale for the entire study</title><p id="P17">The bioinformatic component of this study sought to identify a homologous gene coexpression signature for human and mouse RG cells that is robust across multiple sampling strategies/technology platforms and can be normalized to facilitate comparisons within and between species. This pipeline illustrates the steps that were taken to identify, integrate, and compare RG gene coexpression signatures in eight transcriptomic datasets generated from prenatal human and mouse neocortex.</p></caption><graphic xlink:href="nihms636238f4"/></fig><fig id="F5" orientation="portrait" position="anchor"><label>Extended Data Figure 5</label><caption><title>Genome-wide predictions of expression specificity for hRG and mRG are robust across independent datasets</title><p id="P18"><bold>a-b,</bold> Heat maps of Spearman correlation coefficients for predicted RG expression specificity (RG.PR) over 10,929 genes present in all five human datasets (<bold>a</bold>) and 10,649 genes present in all three mouse datasets (<bold>b</bold>) (as indicated in columns BE and BI in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>). Datasets are denoted by the sample ages listed in <xref rid="T1" ref-type="table">Extended Data Table 1</xref>, though factors besides age also contribute to the observed correlations (e.g. choice of technology platform, sample preparation strategy, etc.). E: embryonic, GW: gestational week.</p></caption><graphic xlink:href="nihms636238f5"/></fig><fig id="F6" orientation="portrait" position="anchor"><label>Extended Data Figure 6</label><caption><title><italic>In situ</italic> hybridization (ISH) validates predicted presence or absence of gene expression in hRG and mRG</title><p id="P19"><bold>a,</bold> Pink: human <italic>in situ</italic> probes for 6 genes predicted to be expressed by hRG but not mRG were generated and hybridized in GW15 human neocortical tissue to validate predicted hRG expression (human scale bar 200 &#x003bc;m). Blue (Eurexpress<sup><xref rid="R21" ref-type="bibr">21</xref></sup>: <ext-link ext-link-type="uri" xlink:href="http://www.eurexpress.org/ee/">http://www.eurexpress.org/ee/</ext-link>): <italic>in situ</italic> hybridizations for 13 genes predicted to be expressed by hRG but not mRG reveal no expression by mRG in E14.5 mouse cortex. Green: mouse <italic>in situ</italic> probes for 3 genes predicted to be expressed by hRG but not mRG were generated and revealed no expression by mRG (E13.5). Positive control expression in cells other than RG are labeled in red. <bold>b,</bold> Expression patterns of genes predicted to be expressed by mRG (i.e. those with the highest 
<inline-formula><mml:math id="M14" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>mRG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula> values in <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>) are shown as further validation (Blue [E14.5, Eurexpress<sup><xref rid="R21" ref-type="bibr">21</xref></sup>: <ext-link ext-link-type="uri" xlink:href="http://www.eurexpress.org/ee/">http://www.eurexpress.org/ee/</ext-link>]; Orange [E14.5, GenePaint<sup>31</sup>: <ext-link ext-link-type="uri" xlink:href="http://www.genepaint.org">http://www.genepaint.org</ext-link>]; mouse scale bars &#x0223c;500 &#x003bc;m). One other gene in the top 15, <italic>Cks2</italic>, is not shown, but was validated by Ajioka et al., 2006<sup>32</sup>.</p></caption><graphic xlink:href="nihms636238f6"/></fig><fig id="F7" orientation="portrait" position="anchor"><label>Extended Data Figure 7</label><caption><title><italic>PDGFD</italic> is expressed by neocortical RG during neurogenesis in humans, but not mice</title><p id="P20"><bold>a,</bold>
<italic>In situ</italic> hybridization of <italic>PDGFD</italic> in GW14.5, 16.5, 17.3, and 18.2 human neocortex demonstrates consistent expression in RG across multiple ages (scale bar 200 &#x003bc;m). <bold>b,</bold>
<italic>In situ</italic> hybridization of <italic>Pdgfd</italic> in E14.5 mouse (Eurexpress<sup><xref rid="R21" ref-type="bibr">21</xref></sup>: <ext-link ext-link-type="uri" xlink:href="http://www.eurexpress.org/ee/">http://www.eurexpress.org/ee/</ext-link>) demonstrates lack of expression (scale bar &#x0223c;500 &#x003bc;m). <bold>c,</bold> To demonstrate the lack of <italic>Pdgfd</italic> expression in mouse neocortex across multiple ages, a pCAG-<italic>PDGFD</italic>-IG expression plasmid was electroporated into the mouse VZ at E13.5 as an internal positive control and harvested at E14.5, E15.5, or E17.5. At E14.5 and E15.5, <italic>Pdgfd</italic> (blue signal) is seen only in the electroporated region in the ventricular zone (scale bar 200 &#x003bc;m, inset scale bar 50 &#x003bc;m). At E17.5, <italic>Pdgfd</italic> is in the cortical plate, and not in the ventricular zone or anywhere else (scale bar 500 &#x003bc;m, inset scale bar 50 &#x003bc;m). VZ: ventricular zone, (I/O)SVZ: (inner/outer) subventricular zone.</p></caption><graphic xlink:href="nihms636238f7"/></fig><fig id="F8" orientation="portrait" position="anchor"><label>Extended Data Figure 8</label><caption><title><italic>Pdgfr&#x003b2;</italic> is strongly expressed by ventral RG and weakly expressed by lateral RG in mice</title><p id="P21"><italic>In situ</italic> hybridization of <italic>Pdgfr&#x003b2;</italic> in sagittal sections through the mouse forebrain (E14.5) across a medial-lateral axis (Eurexpress<sup><xref rid="R21" ref-type="bibr">21</xref></sup>: <ext-link ext-link-type="uri" xlink:href="http://www.eurexpress.org/ee/">http://www.eurexpress.org/ee/</ext-link>) demonstrates progenitor expression in the ventral germinal regions. This expression extends into the dorsal cortex in the lateral aspect of the brain, but is not widespread. In contrast, no progenitor expression is detected in dorsomedial cortex (scale bar 500 &#x003bc;m, inset scale bar 100 &#x003bc;m). Expression is also detected in the pia and vascular pericytes. VZ: ventricular zone, SVZ: subventricular zone.</p></caption><graphic xlink:href="nihms636238f8"/></fig><fig id="F9" orientation="portrait" position="anchor"><label>Extended Data Figure 9</label><caption><title>Manipulation of PDGFR&#x000df; signaling in human and mouse neocortex</title><p id="P22"><bold>a-d,</bold> Chemical blockade of PDGFR&#x000df; signaling in cultured slices of GW14.5 human neocortex impairs RG cell cycle progression. Four pharmacological inhibitors of PDGFR&#x000df; signaling were screened at different concentrations to determine their effects on RG proliferation in cultured slices of GW17.5 human neocortex (2 days). Slices were treated with BrdU for the duration of the experiment and RG proliferation was quantified as the fraction of SOX2+ cells that incorporated BrdU following treatment with inhibitor or vehicle. Statistical significance was assessed with the Wilcoxon rank sum test using the 
<preformat>wilcox.test</preformat> R function with default settings. Images derived from &#x02265;3 slices in each condition. Control + DMSO n = 18; control no DMSO n = 9; CP673451 all conc. n = 9; Sutent all conc. n = 6; Imatinib [0.1&#x003bc;M, 10&#x003bc;M] n = 9, [100&#x003bc;M] n = 6; Tivozanib [1&#x003bc;M, 10&#x003bc;M] n = 9, [0.1&#x003bc;M] n = 6. Significance indicated by: n.s. P &#x0003e; 0.05, **P &#x02264; 0.01, ***P &#x02264; 0.001, ****P &#x02264; 0.0001. <bold>e,</bold> Slice cultures of E13.5 mouse neocortex were treated with BrdU and DMSO (control) or a pharmacological inhibitor of PDGFR&#x000df; signaling (CP673451) for 1 or 2 d (slices from at least 3 independent litters). RG (SOX2+) or IP (TBR2+) cell proliferation was assessed as the fraction each population that incorporated BrdU or was Ki67+ (1d: n = 10 [DMSO] vs. n = 9 [CP673451]; 2d: n = 11 [DMSO] vs. n = 9 [CP673451]). This experiment serves as a negative control to compare with the human. <bold>f,</bold> Ectopic PDGFR&#x000df; signaling promotes RG identity in E13.5 mouse neocortex. <italic>In utero</italic> electroporation of constitutively active TEL-PDGFR&#x003b2;<sup><xref rid="R24" ref-type="bibr">24</xref></sup> was compared with control (mouse E13.5-E15.5) and assessed for the proportion and distribution of SOX2+ RG cells or Ki67+ progenitors (out of GFP+) in the cortical wall (quantified in <bold>g</bold>: at least n = 3 slices per embryo from 2 independent litters, n = 15 [control]; n = 18 [TEL-PDGFR&#x003b2;] or [PDGFR&#x003b2;:D850V]; scale bar 50 &#x003bc;m). Ki67+GFP+ cell quantification following PDGFR&#x003b2;:D850V<sup><xref rid="R23" ref-type="bibr">23</xref></sup> electroporation was performed in a similar fashion and is also shown. The spatial distributions of RG (GFP+SOX2+) in the cortical wall were assessed by quantitative image analysis (spanning ventricle to pia). The grey band delineates a 95% confidence interval for a test of equal univariate densities based on 10,000 permutations. All error bars represent mean +/- s.e.m. Statistical significance for the effects of treatment was calculated by ANOVA of multiple linear regression while controlling for individual (<bold>e</bold>) and litter (<bold>f</bold>) variability (significance indicated by: n.s. P &#x0003e; 0.05, *P &#x02264; 0.05, **P &#x02264; 0.01, ***P &#x02264; 0.001, ****P &#x02264; 0.0001). VZ: ventricular zone.</p></caption><graphic xlink:href="nihms636238f9"/></fig><table-wrap id="T1" position="anchor" orientation="portrait"><label>Extended Data Table 1</label><caption><title>Characteristics of additional gene expression datasets analyzed in the present study</title><p id="P23">Unsupervised gene coexpression analysis was performed for each dataset using the same parameters, followed by unbiased enrichment analysis with the FACS-mRG gene set (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>; <xref rid="F1" ref-type="fig">Extended Data Fig. 1</xref>). &#x0201c;mRG enrichment P-value&#x0201d; denotes the P-value (Fisher's exact test) for the module with the most significant enrichment in each dataset. ABI: Allen Institute for Brain Science, CTX: cortex, E: embryonic, FACS: fluorescence-activated cell sorting, GW: gestational week, LMD: laser-microdissection, Macro: macrodissection, OR: odds ratio [95% confidence interval].</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1">Dataset</th><th valign="top" align="center" rowspan="1" colspan="1">Platform</th><th valign="top" align="center" rowspan="1" colspan="1">Species</th><th valign="top" align="center" rowspan="1" colspan="1">CTX prep</th><th valign="top" align="center" rowspan="1" colspan="1">Age</th><th valign="top" align="center" rowspan="1" colspan="1">Samples</th><th valign="top" align="center" rowspan="1" colspan="1">mRG inrichment P-value</th><th valign="top" align="center" rowspan="1" colspan="1">OR</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">ABI.1<sup><xref rid="R13" ref-type="bibr">13</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Agilent</td><td align="center" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">LMD</td><td align="center" valign="top" rowspan="1" colspan="1">GW17</td><td align="center" valign="top" rowspan="1" colspan="1">179</td><td align="center" valign="top" rowspan="1" colspan="1">2.6e-39</td><td align="center" valign="top" rowspan="1" colspan="1">7.2 [5.5-9.5]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">ABI.2<sup><xref rid="R13" ref-type="bibr">13</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Agilent</td><td align="center" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">LMD</td><td align="center" valign="top" rowspan="1" colspan="1">GW18</td><td align="center" valign="top" rowspan="1" colspan="1">168</td><td align="center" valign="top" rowspan="1" colspan="1">9.7e-35</td><td align="center" valign="top" rowspan="1" colspan="1">7.5 [5.6-10.0]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">BrainSpan<sup><xref rid="R17" ref-type="bibr">17</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">RNAseq</td><td align="center" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">Macro</td><td align="center" valign="top" rowspan="1" colspan="1">GW10-18</td><td align="center" valign="top" rowspan="1" colspan="1">107</td><td align="center" valign="top" rowspan="1" colspan="1">2.0e-47</td><td align="center" valign="top" rowspan="1" colspan="1">9.2 [6.9-12.1]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Fietz et al.<sup><xref rid="R12" ref-type="bibr">12</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">RNAseq</td><td align="center" valign="top" rowspan="1" colspan="1">Human</td><td align="center" valign="top" rowspan="1" colspan="1">LMD</td><td align="center" valign="top" rowspan="1" colspan="1">GW15-18</td><td align="center" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">1.3e-39</td><td align="center" valign="top" rowspan="1" colspan="1">8.4 [6.3-11.1]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Fietz et al.<sup><xref rid="R12" ref-type="bibr">12</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">RNAseq</td><td align="center" valign="top" rowspan="1" colspan="1">Mouse</td><td align="center" valign="top" rowspan="1" colspan="1">LMD</td><td align="center" valign="top" rowspan="1" colspan="1">E14.5</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">1.3e-73</td><td align="center" valign="top" rowspan="1" colspan="1">12.5 [9.6-16.4]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Kawaguchi et al.<sup><xref rid="R18" ref-type="bibr">18</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Affymetrix</td><td align="center" valign="top" rowspan="1" colspan="1">Mouse</td><td align="center" valign="top" rowspan="1" colspan="1">Single Cell</td><td align="center" valign="top" rowspan="1" colspan="1">E14</td><td align="center" valign="top" rowspan="1" colspan="1">70</td><td align="center" valign="top" rowspan="1" colspan="1">3.1e-34</td><td align="center" valign="top" rowspan="1" colspan="1">59.0 [34.2-100.6]</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Pinto et al.<sup><xref rid="R19" ref-type="bibr">19</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">Affymetrix</td><td align="center" valign="top" rowspan="1" colspan="1">Mouse</td><td align="center" valign="top" rowspan="1" colspan="1">FACS</td><td align="center" valign="top" rowspan="1" colspan="1">E14-18</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">7.8e-46</td><td align="center" valign="top" rowspan="1" colspan="1">20.7 [14.7-29.0]</td></tr></tbody></table></table-wrap></sec><sec sec-type="supplementary-material" id="S3"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS636238-supplement-1.pdf" orientation="portrait" xlink:type="simple" id="d37e1468" position="anchor"/></supplementary-material></sec></body><back><ack id="S4"><p>We thank the staff at San Francisco General Hospital Women's Options Center for their consideration in allowing access to donated human prenatal tissue. We thank Joe DeYoung and the staff at the Southern California Genotyping Consortium at the University of California Los Angeles for microarray data generation. We are grateful to Alisha Holloway for her critical reading of the manuscript, and also thank W. Walantus, S. Wang, Y. Wang and other University of California San Francisco personnel for technical and administrative support. We thank C. Stiles and D. Rowitch for the TEL-PDGFR&#x003b2; construct. Due to space limitations, we apologize that many primary and historical publications have not been cited. This work was supported by grants from the N.I.H., the Bernard Osher Foundation, a California Institute for Regenerative Medicine Predoctoral Fellowship for J.H.L. (TG2-01153), a Damon Runyon Foundation Postdoctoral Fellowship for A.A.P. (DRG-2013), and the University of California San Francisco Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation (M.C.O). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the California Institute for Regenerative Medicine or any other agency of the State of California.</p></ack><fn-group><fn id="FN1"><p>Reprints and permissions information is available at <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/reprints">www.nature.com/reprints</ext-link>.</p></fn><fn id="FN4" fn-type="conflict"><p>The authors declare no conflict of interests.</p></fn><fn id="FN5" fn-type="con"><p><bold>AUTHOR CONTRIBUTIONS</bold>: M.C.O. conceived the GCASS strategy and J.H.L generated the GCASS dataset. A.J. generated the FACS-mRG dataset. M.C.O. conceived, designed, and performed the bioinformatic analyses. J.H.L., T.J.N., and A.A.P. designed and performed the experiments leading up to the prioritization of PDGFD as the focus of this study. T.J.N. performed the majority of the <italic>in situ</italic> hybridizations and the <italic>in vivo</italic> mouse experiments. J.H.L. performed the human and mouse slice culture experiments, as well as all of the immunostaining, imaging, and image analysis in the study. M.C.O. and J.H.L. wrote the manuscript, which was edited by all the authors. M.C.O. and A.R.K provided conceptual guidance at every stage of the project.</p></fn><fn id="FN6"><p><bold>Statements</bold>: Microarray data from the GCASS dataset have been deposited in Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>) under accession ID GSE62064.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakic</surname><given-names>P</given-names></name></person-group><article-title>Evolution of the neocortex: a perspective from developmental biology</article-title><source>Nat Rev Neurosci</source><volume>10</volume><issue>10</issue><fpage>724</fpage><year>2009</year><pub-id pub-id-type="pmid">19763105</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lui</surname><given-names>JH</given-names></name><name><surname>Hansen</surname><given-names>DV</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><article-title>Development and evolution of the human neocortex</article-title><source>Cell</source><volume>146</volume><issue>1</issue><fpage>18</fpage><year>2011</year><pub-id pub-id-type="pmid">21729779</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smart</surname><given-names>IH</given-names></name><etal/></person-group><article-title>Unique morphological features of the proliferative zones and postmitotic compartments of the neural epithelium giving rise to striate and extrastriate cortex in the monkey</article-title><source>Cereb Cortex</source><volume>12</volume><issue>1</issue><fpage>37</fpage><year>2002</year><pub-id pub-id-type="pmid">11734531</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>DV</given-names></name><name><surname>Lui</surname><given-names>JH</given-names></name><name><surname>Parker</surname><given-names>PR</given-names></name><name><surname>Kriegstein</surname><given-names>AR</given-names></name></person-group><article-title>Neurogenic radial glia in the outer subventricular zone of human neocortex</article-title><source>Nature</source><volume>464</volume><issue>7288</issue><fpage>554</fpage><year>2010</year><pub-id pub-id-type="pmid">20154730</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fietz</surname><given-names>SA</given-names></name><etal/></person-group><article-title>OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling</article-title><source>Nat Neurosci</source><year>2010</year></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergsten</surname><given-names>E</given-names></name><etal/></person-group><article-title>PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor</article-title><source>Nat Cell Biol</source><volume>3</volume><issue>5</issue><fpage>512</fpage><year>2001</year><pub-id pub-id-type="pmid">11331881</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaRochelle</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>PDGF-D, a new protease-activated growth factor</article-title><source>Nat Cell Biol</source><volume>3</volume><issue>5</issue><fpage>517</fpage><year>2001</year><pub-id pub-id-type="pmid">11331882</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakic</surname><given-names>P</given-names></name></person-group><article-title>Specification of cerebral cortical areas</article-title><source>Science</source><volume>241</volume><issue>4862</issue><fpage>170</fpage><year>1988</year><pub-id pub-id-type="pmid">3291116</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Oldham</surname><given-names>MC</given-names></name></person-group><article-title>Transcriptomics: from differential expression to coexpression</article-title><source>The OMICs: Applications in Neuroscienc</source><person-group person-group-type="editor"><name><surname>Coppola</surname><given-names>G</given-names></name></person-group><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford</publisher-loc><year>2014</year><volume>1</volume><fpage>85</fpage></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldham</surname><given-names>MC</given-names></name></person-group><article-title>Functional organization of the transcriptome in human brain</article-title><source>Nat Neurosci</source><volume>11</volume><issue>11</issue><fpage>1271</fpage><year>2008</year><pub-id pub-id-type="pmid">18849986</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Workman</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Modeling transformations of neurodevelopmental sequences across mammalian species</article-title><source>J Neurosci</source><volume>33</volume><fpage>7368</fpage><year>2013</year><pub-id pub-id-type="pmid">23616543</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fietz</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Transcriptomes of germinal zones of human and mouse fetal neocortex suggest a role of extracellular matrix in progenitor self-renewal</article-title><source>Proc Natl Acad Sci U S A</source><volume>109</volume><issue>29</issue><fpage>11836</fpage><year>2012</year><pub-id pub-id-type="pmid">22753484</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Transcriptional landscape of the prenatal human brain</article-title><source>Nature</source><year>2014</year></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name></person-group><article-title>Geometric interpretation of gene coexpression network analysis</article-title><source>PLoS Comput Biol</source><volume>4</volume><issue>8</issue><fpage>e1000117</fpage><year>2008</year><pub-id pub-id-type="pmid">18704157</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oldham</surname><given-names>MC</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><article-title>Conservation and evolution of gene coexpression networks in human and chimpanzee brains</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><issue>47</issue><fpage>17973</fpage><year>2006</year><pub-id pub-id-type="pmid">17101986</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>A general framework for weighted gene co-expression network analysis</article-title><source>Stat Appl Genet Mol Biol</source><volume>4</volume><comment>Article17</comment><year>2005</year></element-citation></ref><ref id="R17"><element-citation publication-type="web"><collab>BrainSpan</collab><comment><ext-link ext-link-type="uri" xlink:href="http://www.brainspan.org/rnaseq/search/index.html">http://www.brainspan.org/rnaseq/search/index.html</ext-link></comment></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Single-cell gene profiling defines differential progenitor subclasses in mammalian neurogenesis</article-title><source>Development</source><volume>135</volume><issue>18</issue><fpage>3113</fpage><year>2008</year><pub-id pub-id-type="pmid">18725516</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>L</given-names></name><etal/></person-group><article-title>Prospective isolation of functionally distinct radial glial subtypes--lineage and transcriptome analysis</article-title><source>Mol Cell Neurosci</source><volume>38</volume><issue>1</issue><fpage>15</fpage><year>2008</year><pub-id pub-id-type="pmid">18372191</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Emerging roles of PDGF-D signaling pathway in tumor development and progression</article-title><source>Biochim Biophys Acta</source><volume>1806</volume><issue>1</issue><fpage>122</fpage><year>2010</year><pub-id pub-id-type="pmid">20434526</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diez-Roux</surname><given-names>G</given-names></name><etal/></person-group><article-title>A high-resolution anatomical atlas of the transcriptome in the mouse embryo</article-title><source>PLoS Biol</source><volume>9</volume><issue>1</issue><fpage>e1000582</fpage><year>2011</year><pub-id pub-id-type="pmid">21267068</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>WG</given-names></name><etal/></person-group><article-title>Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451</article-title><source>Cancer Res</source><volume>65</volume><issue>3</issue><fpage>957</fpage><year>2005</year><pub-id pub-id-type="pmid">15705896</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magnusson</surname><given-names>PU</given-names></name><etal/></person-group><article-title>Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>27</volume><issue>10</issue><fpage>2142</fpage><year>2007</year><pub-id pub-id-type="pmid">17656670</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golub</surname><given-names>TR</given-names></name><name><surname>Barker</surname><given-names>GF</given-names></name><name><surname>Lovett</surname><given-names>M</given-names></name><name><surname>Gilliland</surname><given-names>DG</given-names></name></person-group><article-title>Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation</article-title><source>Cell</source><volume>77</volume><issue>2</issue><fpage>307</fpage><year>1994</year><pub-id pub-id-type="pmid">8168137</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Human-specific loss of regulatory DNA and the evolution of human-specific traits</article-title><source>Nature</source><volume>471</volume><issue>7337</issue><fpage>216</fpage><year>2011</year><pub-id pub-id-type="pmid">21390129</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>BI</given-names></name><etal/></person-group><article-title>Evolutionarily dynamic alternative splicing of GPR56 regulates regional cerebral cortical patterning</article-title><source>Science</source><volume>343</volume><issue>6172</issue><fpage>764</fpage><year>2014</year><pub-id pub-id-type="pmid">24531968</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Rakic</surname><given-names>P</given-names></name></person-group><article-title>Cortical evolution: judge the brain by its cover</article-title><source>Neuron</source><volume>80</volume><issue>3</issue><fpage>633</fpage><year>2013</year><pub-id pub-id-type="pmid">24183016</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Functional and evolutionary insights into human brain development through global transcriptome analysis</article-title><source>Neuron</source><volume>62</volume><issue>4</issue><fpage>494</fpage><year>2009</year><pub-id pub-id-type="pmid">19477152</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>HJ</given-names></name></person-group><article-title>Spatio-temporal transcriptome of the human brain</article-title><source>Nature</source><volume>478</volume><issue>7370</issue><fpage>483</fpage><year>2011</year><pub-id pub-id-type="pmid">22031440</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>An anatomically comprehensive atlas of the adult human brain transcriptome</article-title><source>Nature</source><volume>489</volume><issue>7416</issue><fpage>391</fpage><year>2012</year><pub-id pub-id-type="pmid">22996553</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F10" orientation="portrait" position="float"><label>Figure 1</label><caption><title>GCASS identifies a transcriptional signature of radial glia (RG) in human neocortex</title><p><bold>Left</bold> Conceptual framework. <bold>a,</bold> Transcriptional profiling of serial sections (n = 87, Illumina HT12v4 microarrays) from a GW14.5 human neocortical specimen (scale bar 2.5 mm). <bold>b,</bold> Genes with similar expression patterns are grouped into modules, which may reflect cell typespecific gene coexpression<sup><xref rid="R10" ref-type="bibr">10</xref></sup>. <bold>c,</bold> The transcriptional signature of a module is defined as a list of genes ranked by their correlation to the module eigengene<sup><xref rid="R14" ref-type="bibr">14</xref></sup>. <bold>Right</bold>: Finding human RG modules. <bold>d,</bold> Six out of 55 modules were significantly enriched (Fisher's exact test) with the FACS-mRG gene set. Blue line: P = .05; red line: P = 9.1e-04 (Bonferroni correction). <bold>e,</bold> Genome-wide distribution of predicted GW14.5 neocortical RG expression specificity (<italic>Z.hRG</italic>) based on enriched modules in <bold>(d). f,</bold> ISH confirms RG expression specificity for novel RG genes from <bold>e</bold> (scale bar 300 &#x003bc;m). (I/O)SVZ: inner/outer subventricular zone, SP: subplate, CP: cortical plate.</p></caption><graphic xlink:href="nihms636238f10"/></fig><fig id="F11" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Combined differential RG specificity / differential expression analysis identifies gene expression differences that distinguish neocortical RG between human and mouse</title><p><bold>a,</bold> Predicted RG expression specificity for 15,576 homologous genes in human and mouse. <bold>b,</bold> The core transcriptional architecture of RG. Node size corresponds to connectivity. <bold>c,</bold> Idealized examples of four types of evolutionary change that could drive differences in predicted hRG and mRG expression specificity. <bold>d,</bold> Comparison of differential RG specificity and differential expression for homologous genes between human and mouse. Dashed grey lines delineate arbitrary thresholds (-20, 20) used to define quadrants (1-4) for enrichment analyses (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 4</xref>). Cyan circles highlight 18 genes predicted to be expressed in hRG but not mRG; one of these encodes the growth factor <italic>PDGFD</italic> (<bold>d',</bold> green square). Its cognate receptor <italic>PDGFR&#x003b2;</italic> is also highlighted (<bold>d',</bold> red square).</p></caption><graphic xlink:href="nihms636238f11"/></fig><fig id="F12" orientation="portrait" position="float"><label>Figure 3</label><caption><title>PDGFD and PDGFR&#x000df; are expressed in human but not mouse dorsal RG</title><p>Consensus Pearson correlations among expression levels of <italic>PDGFD</italic> (<bold>a,</bold> human), <italic>Pdgfd</italic> (<bold>b,</bold> mouse), <italic>PDGFR&#x003b2;</italic> (<bold>e,</bold> human), or <italic>Pdgfr&#x003b2;</italic> (<bold>f,</bold> mouse) and 10 genes with the highest 
<inline-formula><mml:math id="M15" overflow="scroll"><mml:mover accent="true"><mml:mrow><mml:mtext>RG</mml:mtext><mml:mo>.</mml:mo><mml:mtext>PR</mml:mtext></mml:mrow><mml:mo>&#x000af;</mml:mo></mml:mover></mml:math></inline-formula>
<bold>c-d,</bold> ISH of <italic>PDGFD</italic> in human (<bold>c,</bold> scale bar 1 mm, inset scale bar 200 &#x003bc;m) and mouse neocortex (<bold>d,</bold> scale bar 200 &#x003bc;m, inset scale bar 50 &#x003bc;m). <bold>g,</bold> Immunostaining of PDGFR&#x000df; in human neocortex (scale bar 1 mm). 63x image of lateral VZ demonstrates co-labeling of PDGFR&#x000df; with pVIM- and SOX2-expressing RG (scale bar 10 &#x003bc;m). The pia and choroid plexus are absent due to human tissue processing. <bold>h,</bold> Immunostaining of PDGFR&#x000df; in mouse neocortex (comparison with pVIM in the lateral ganglionic eminence [LGE]; scale bar 250 &#x003bc;m, inset scale bar 50 &#x003bc;m).</p></caption><graphic xlink:href="nihms636238f12"/></fig><fig id="F13" orientation="portrait" position="float"><label>Figure 4</label><caption><title>PDGFD/PDGFR&#x000df; signaling is necessary for normal cell cycle progression of neocortical RG in humans and sufficient to promote RG identity in mice</title><p><bold>a,</bold> GW17.5 human neocortical slice cultures were treated with BrdU and DMSO (control) or an inhibitor of PDGFR&#x000df; signaling (CP673451) (scale bar 50 &#x003bc;m). The same experiment was performed in E13.5 mouse neocortical slice cultures (slices from at least 3 individuals/litters per species). <bold>b,</bold> RG (IP) proliferation was quantified as the fraction of SOX2+ (TBR2+) cells that incorporated BrdU after 48 hours. RG slice counts: human (n = 18 [DMSO] vs. n = 17 [CP673451]); mouse (n = 13 [DMSO] vs. n = 11 [CP673451]). IP slice counts: human (n = 12 [DMSO] vs. n = 10 [CP673451]); mouse (n = 11 [DMSO] vs. n = 9 [CP673451]). Cell death was quantified in human slices as the fraction of SOX2+ or BrdU+ cells that co-stained for cleaved-caspase 3 (n = 6 [DMSO] vs. n = 7 [CP673451]). <bold>c,</bold>
<italic>In utero</italic> intraventricular injection of recombinant human PDGF-DD protein (mouse E13.5-E15.5). Brain tissue was stained for SOX2 and DAPI (scale bar 50 &#x003bc;m). <bold>d,</bold> Quantification of data from <bold>c</bold> in dorsomedial and lateral cortex (at least n = 3 slices per embryo from 5 litters/experiments [lateral: n = 49 vehicle; n = 47 PDGF-DD; dorsomedial: n = 45 vehicle; n = 39 PDGF-DD]). The distribution of RG in the cortex (from ventricle to pia) was quantified; grey band delineates 95% confidence interval for test of equal univariate densities (n = 10,000 permutations). <bold>e,</bold>
<italic>In utero</italic> electroporation of constitutively active PDGFR&#x003b2;:D850V<sup><xref rid="R23" ref-type="bibr">23</xref></sup> (mouse E13.5-E15.5). Cortex was stained for SOX2; white arrowheads indicate co-labeling with electroporated GFP cells (quantified in <bold>f</bold>: at least n = 3 slices per embryo from 2 litters; n = 15 [control], n = 18 [PDGFR&#x003b2;:D850V]; scale bar 50 &#x003bc;m). Note disrupted epithelial structure of VZ. Error bars = mean +/- s.e.m. Statistical significance for treatment was determined by ANOVA of multiple linear regression after controlling for individual (<bold>b</bold>) or litter (<bold>d, f</bold>) (n.s. P &#x0003e; 0.05, *P &#x02264; 0.05, **P &#x02264; 0.01, ***P &#x02264; 0.001, ****P &#x02264; 0.0001). <bold>g,</bold> Schematic summarizing experimental manipulations and results. LOF: loss-offunction, GOF: gain-of-function.</p></caption><graphic xlink:href="nihms636238f13"/></fig></floats-group></article>